12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Titan preclinical data

In a non-human primate model of PD, Titan's subcutaneous ropinirole implant significantly reduced clinical symptoms of PD over several months as measured by Unified Parkinson's Disease Rating Scale (UPDRS)...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >